FORWARD TO A FRIEND    |    SIGN UP FOR THIS AND OTHER CANCER UPDATES

In the Long Run, Shorter Radiation Schedule Just as Good for Early Cancer
By Laura Beil

The tantalizing idea of cutting radiation treatment time in half got a boost at Thursday afternoon's SABCS session, with doctors predicting that the approach may soon be offered to more women in the United States... [MORE]

We’ve made step-by-step progress in medical therapies for breast cancer in its early stage following surgery and improved survival. What insights have we gained from pooling the results of worldwide clinical trials and how might this affect how we apply treatment and research new therapies? [PLAY VIDEO]

Sir Richard Peto, PhD professor of medical statistics and epidemiology; co-director, Clinical Trial Service Unit; University of Oxford, England

• Zometa Offers Three Years of Bone Benefit: A study released Thursday afternoon reported that Zometa (zoledronic acid), a type of bisphosphonate, appears to increase bone mineral density among women receiving aromatase inhibitors, and the benefit lasts for at least three years... [MORE]

• Some Women Get Less Benefit from Tamoxifen: Cytochrome P450 2D6, or more commonly known as CYP2D6, is a metabolic enzyme that affects the breakdown of a wide range of drugs, including tamoxifen... [MORE]

• Genomics Helps Predict Best Treatment: It’s been known for some time that breast cancer is not just one disease, but a grouping of several different subtypes, including those that overexpress the protein HER2 and those that are fueled from hormones... [MORE]

• International Data May Further Clarify Impact of HRT: Scientists continue working to refine their understanding of the impact of hormone replacement therapy (HRT) on breast cancer rates... [MORE]

SURVIVOR STORY

Miguel Perez
Pink Loafers and Passion
Two volunteers with the Columbus, Ohio, affiliate of Susan G. Komen for the Cure saw the loafers at a shoe store. They were on the men's sale rack because, it seemed, no man was looking for a pair of bright pink leather loafers... [MORE]

IN CASE YOU MISSED IT

Beyond "Cured" (HEAL) The HRT Connection (CURE) Hazardous to Your Heart (CURE)

OTHER RELATED COVERAGE

Test May Spare Many Women Chemotherapy
(Chicago Tribune)

High Dose Fulvestrant Reduces Tumor Cell Growth: Presented at SABCS

(Doctor's Guide)

	>> Debu Tripathy, MD EDITOR-IN-CHIEF, CURE & HEAL MAGAZINES Our genetic diversity is such that our ability to metabolize, or break down, different drugs is quite different from one person to another... [MORE]
	>> Kathy LaTour EDITOR-AT-LARGE, CURE & HEAL MAGAZINES For the past 25 years, Susan G. Komen for the Cure — which until this year was the Susan G. Komen Breast Cancer Foundation — has raised funds for research, education, and a number of other worthwhile goals across the country... [MORE]
	>> Karen Patterson MANAGING EDITOR, HEAL MAGAZINE A presentation Friday morning offered a possible avenue to explain how being overweight raises the risk of getting breast cancer and worsens the prognosis for patients diagnosed with the disease... [MORE]

What have we learned about the individuality and subtypes of breast cancers in the past five years? [PLAY VIDEO]

Cynthia Osborne, MD medical oncologist and breast cancer specialist with Texas Oncology, Baylor/Sammons Cancer Center

COMING TOMORROW

Answering Questions on Sentinel Lymph Node Biopsy

Dealing with Lymphedema

Research into Triple-Negative Breast Cancer

CURE and Heal would like to give a special thanks to the following non-profit partners
for making this information available to their constituents:
American Cancer Society • People Living with Cancer
HER2 Support • Inflammatory Breast Cancer Research Fund • Men Against Breast Cancer
National Breast Cancer Coalition • Pink-Link